Literature DB >> 1391959

Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization.

E Kondo1, S Nakamura, H Onoue, Y Matsuo, T Yoshino, H Aoki, K Hayashi, K Takahashi, J Minowada, S Nomura.   

Abstract

bcl-2 protein has been detected in surgical specimens and cultured permanent cell lines of non-Hodgkin's lymphomas and leukemias using enzyme immunohistochemistry and immunofluorescence with anti-bcl-2 monoclonal antibodies. Of 40 surgical specimens, bcl-2 protein was expressed in 50% of B-cell and 41% of T-cell lymphomas, both with and without the bcl-2 gene rearrangement. In investigations of 38 hematopoietic cell lines, bcl-2 protein was detected not only in lymphoid cell lines but also in myeloid cell lines. In situ hybridization and immunohistochemical analysis of reactive lymph nodes showed that lymphocytes in mantle zones and paracortical areas expressed bcl-2 protein consistent with the messenger RNA distribution and that germinal center cells showed abundant bcl-2 transcript, despite the absence of detectable bcl-2 protein. These results suggest that bcl-2 protein is broadly expressed in various hematopoietic neoplasms not restricted in t(14; 18) lymphomas and that germinal center cells may be involved in some arrest of bcl-2 protein expression at the posttranscriptional level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391959

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  The synthesis of Bcl-2 and other proteins in the neoplastic follicles of follicular lymphoma.

Authors:  I A Lampert
Journal:  Mol Pathol       Date:  1999-02

2.  Primary gastrointestinal follicular center lymphoma resembling multiple lymphomatous polyposis.

Authors:  Y Sakata; R Iwakiri; H Sakata; J Fujisaki; M Mizuguchi; N Fukushima; K Fujimoto
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

3.  miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells.

Authors:  Shaun Willimott; Simon D Wagner
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

4.  The BCL-2 5' untranslated region contains an RNA G-quadruplex-forming motif that modulates protein expression.

Authors:  Ramla Shahid; Anthony Bugaut; Shankar Balasubramanian
Journal:  Biochemistry       Date:  2010-09-28       Impact factor: 3.162

5.  Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study.

Authors:  D Schiffer; P Cavalla; A Migheli; M T Giordana; L Chiadò-Piat
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

6.  Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.

Authors:  Wyndham H Wilson; Owen A O'Connor; Myron S Czuczman; Ann S LaCasce; John F Gerecitano; John P Leonard; Anil Tulpule; Kieron Dunleavy; Hao Xiong; Yi-Lin Chiu; Yue Cui; Todd Busman; Steven W Elmore; Saul H Rosenberg; Andrew P Krivoshik; Sari H Enschede; Rod A Humerickhouse
Journal:  Lancet Oncol       Date:  2010-11-18       Impact factor: 41.316

7.  The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.

Authors:  Weimin Ci; Jose M Polo; Leandro Cerchietti; Rita Shaknovich; Ling Wang; Shao Ning Yang; Kenny Ye; Pedro Farinha; Douglas E Horsman; Randy D Gascoyne; Olivier Elemento; Ari Melnick
Journal:  Blood       Date:  2009-03-23       Impact factor: 22.113

8.  Expression of the bcl-2 protein in B cell lymphomas arising from mucosa associated lymphoid tissue.

Authors:  E Navratil; P Gaulard; P Kanavaros; J Audouin; J Bougaran; N Martin; J Diebold; D Y Mason
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

9.  Small cell carcinomas of the lung express the Bcl-2 protein.

Authors:  J M Ben-Ezra; M J Kornstein; M M Grimes; G Krystal
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

10.  The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood.

Authors:  A Claviez; M Tiemann; J Peters; H Kreipe; R Schneppenheim; R Parwaresch
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.